Summary:
We studied 622 transplants undertaken between 1982 and 2001 to: (1) determine the incidence, timing and etiology of bacteremias, and (2) examine the ability of routine surveillance cultures to predict bacteremias. A total of 404 episodes (0.65 episode per patient) occurred in 248 patients, due to coagulase-negative staphylococci (n=171, 42%), Gram-negative bacteria (n=129, 32%), streptococci (n=48, 12%), other Gram-positive bacteria (n=33, 8%), anaerobes (n=9, 2%) and fungi (n=14, 3%). Bacteremias were more frequent in allogeneic (0.96 episode/patient) compared to autologous (0.44) transplants (P<0.0001). The overall incidence decreased from 0.92 episode/patient until 1990 to 0.66 in 1991–1996 and 0.55 in 1997–2001 (P<0.0001), but this was only observed in autologous transplants. Among them, 212 (53%) occurred before hospital discharge and 192 (47%) thereafter. This proportion was lower for coagulase-negative staphylococci, other Gram-positive bacteria and Gram-negative bacteria compared to other agents (P=0.001). In 50% of the cases, the agent responsible for the bacteremic episode was present in routine surveillance cultures previously. In conclusion: (1) bacteremias remain a frequent complication, particularly in allogeneic transplantation, even long after hospital discharge; (2) routine surveillance cultures can predict bacteremias in 50% of the cases, but the practical impact of this observation is limited in view of the costs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kolbe K, Domkin D, Derigs HG et al. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 143–147.
Yuen KY, Woo PCY, Hui CH et al. Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment. Bone Marrow Transplant 1998; 21: 1137–1143.
Collin BA, Leather HL, Wingard JR et al. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33: 947–953.
Riley DK, Pavia AT, Beatty PG et al. Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful ? Bone Marrow Transplant 1995; 15: 469–473.
Newman KA, Schimpff SC, Young VM et al. Lessons learned from surveillance cultures in patients with acute non-lymphocytic leukemia. Am J Med 1981; 70: 423–431.
Kramer BS, Pizzo PA, Robichaud KJ et al. Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia. Am J Med 1982; 72: 561–568.
Cohen ML, Murphy MT, Counts GW et al. Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment. J Infect Dis 1983; 147: 789–793.
Daw MA, MacMahon E, Keane CT . Surveillance cultures in the neutropenic patient. J Hosp Infect 1988; 12: 251–261.
González-Barca E, Fernández-Sevilla A, Carratalá et al. Eur J Clin Microbiol Infect Dis 1996; 15: 291–296.
Krüger W, Rüssmann B, Kröger N et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation – a 7 year single centre investigation of 409 cases. Bone Marrow Transplantat 1999; 23: 589–597.
Elishoov H, Or R, Strauss N et al. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipient. Medicine 1998; 77: 83–101.
Williamson ECM, Millar M, Steward CG et al. Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 1999; 104: 560–568.
Aksu G, Ruhi MZ, Akan H et al. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Bone Marrow Transplant 2001; 27: 201–205.
Engelhard D, Elishoov H, Strauss N et al. Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. Transplantation 1996; 61: 430–434.
Elting LS, Rubenstein EB, Rolston KVI et al. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997; 25: 247–259.
Castagnola E, Garaventa A, Viscoli E et al. Changing pattern of pathogens causing Broviac catheter-related bacteremias in children with cancer. J Hosp Infect 1995; 29: 129–133.
Viscoli C, Castagnola E, Giacchino M et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Eur J Cancer 1999; 35: 770–774.
Frère P, Hermanne JP, Debouge MH et al. Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2002; 29: 589–594.
Larocco MT, Burgert SJ . Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev 1997, 277–297.
Keung YK, Watkins K, Chen SC et al. Increased incidence of central venous catheter-related infections in bone marrow transplant patients. Am J Clin Oncol 1995; 18: 469–474.
Person ML, Abrutyn E . Reducing the risk for catheter-related infections: a new strategy. Ann Intern Med 1997; 127: 304–306.
Hoyle C, Goldman JM . Life-threatening infections occurring more than 3 months after BMT. Bone Marrow Transplant 1994; 14: 247–252.
Nasser RM, Hajjar I, Sandhaus LM et al. Routine cultures of bone marrow and peripheral stem cell harvests: clinical impact, cost analysis, and review. Clin Infect Dis 1998; 27: 886–888.
Serody JS, Berrey MM, Albritton K et al. Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant 2000; 26: 533–538.
Waltzman ML, Harper M . Financial and clinical impact of false-positive blood culture results. Clin Infect Dis 2001; 33: 296–299.
Grace CJ, Lieberman J, Pierce K et al. Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 2001; 32: 1651–1655.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Frère, P., Hermanne, JP., Debouge, MH. et al. Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplant 33, 745–749 (2004). https://doi.org/10.1038/sj.bmt.1704414
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704414
Keywords
This article is cited by
-
Low pre-transplant levels of mannose-binding lectin are associated with viral infections and mortality after haematopoietic allogeneic stem cell transplantation
BMC Immunology (2019)
-
The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study
BMC Infectious Diseases (2018)
-
Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms—Where Are We Today?
Current Hematologic Malignancy Reports (2018)
-
Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis
Bone Marrow Transplantation (2017)
-
Bacteremia During Early Post-allogeneic Hematopoietic Stem Cell Transplantation Period: A Single Center Experience
Indian Journal of Hematology and Blood Transfusion (2017)